期刊文献+

肿瘤缓解分级和ERCC1核蛋白表达可以预测胃食管肿瘤患者新辅助化疗的临床效果

Tumour Regression and ERCC1 Nuclear Protein Expression Predict Clinical Outcome in Patients with Gastro-Oesophageal Cancer Treated with Neoadjuvant Chemotherapy
下载PDF
导出
摘要 1文献来源 Fareed KR,Al-Attar A,Soomro IN,et al.Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy[J].Br J Cancer,2010,102(11):1600-1607.
出处 《循证医学》 CSCD 2011年第2期91-93,共3页 The Journal of Evidence-Based Medicine
关键词 胃食管肿瘤 新辅助化疗 肿瘤缓解分级 ERCC1 APE1 P53 gastro-oesophageal neoplasms neoadjuvant chemotherapy tumour regression grade ERCC1 APE1 p53
  • 相关文献

参考文献3

  • 1Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone resectable gastroesophageal cancer [J]. N Engl J Med, 2006,355(1): 11-20.
  • 2Lerut T, Moons J, Coosemans W, et al. Multidisciplinary treatment of advanced cancer of the esophagus and gastroesophageal junction: A European center's approach [J]. Surg Oncol Clin North Am, 2008,17 (3) : 485-502.
  • 3Lordick F, Ott K, Krause BJ, et al. PET to assess early metabolic response and to guilde treatment of adenocarcinoma of the oesophagogastric junction: The MUNICON phase II trial [J]. Lancet, 2007,8(9) :797-805.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部